We are live on ! Find out more
RIM

RS Investment Management Portfolio holdings

AUM $9.73B
1-Year Est. Return 3.24%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+3.24%
3 Year Est. Return
+50.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.73B
AUM Growth
-$385M
Cap. Flow
-$739M
Cap. Flow %
-7.6%
Top 10 Hldgs %
14.92%
Holding
438
New
62
Increased
134
Reduced
162
Closed
56

Top Buys

Rank Stock Value
1
KEX icon
Kirby Corp
KEX
+$55M
2
IART icon
Integra LifeSciences
IART
+$51.1M
3
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
+$45.4M
4
WBMD
WebMD Health Corp.
WBMD
+$43.4M
5
NGVT icon
Ingevity
NGVT
+$39.8M

Top Sells

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$81.5M
2
STE icon
Steris
STE
+$57.7M
3
RRGB icon
Red Robin
RRGB
+$56.8M
4
DG icon
Dollar General
DG
+$52.6M
5
ZBRA icon
Zebra Technologies
ZBRA
+$48.1M

Sector Composition

Rank Sector Weight
1 Technology 18.31%
2 Healthcare 15.94%
3 Financials 14.68%
4 Consumer Discretionary 13.08%
5 Industrials 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPG icon
326
Simon Property Group
SPG
$66.2B
$988K 0.01%
4,554
+1,149
+34% +$234K
RARE icon
327
Ultragenyx Pharmaceutical
RARE
$1.29B
$978K 0.01%
20,000
-390,548
-95% -$25.3M
OOMA icon
328
Ooma
OOMA
$630M
$929K 0.01%
113,410
-99,600
-47% -$707K
MMM icon
329
3M
MMM
$84.3B
$834K 0.01%
5,699
– –
UBS icon
330
UBS Group
UBS
$157B
$834K 0.01%
66,354
– –
CSCO icon
331
Cisco
CSCO
$436B
$813K 0.01%
28,333
+4,458
+19% +$125K
SCOR icon
332
Comscore
SCOR
$75.9M
$807K 0.01%
1,691
-44,283
-96% -$26.5M
TXN icon
333
Texas Instruments
TXN
$241B
$759K 0.01%
12,108
+1,430
+13% +$85K
VZ icon
334
Verizon
VZ
$214B
$718K 0.01%
12,861
-308
-2% -$16K
TJX icon
335
TJX Companies
TJX
$137B
$715K 0.01%
18,522
– –
TWTR
336
DELISTED
Twitter, Inc.
TWTR
$656K 0.01%
38,780
-15,270
-28% -$238K
ETN icon
337
Eaton
ETN
$153B
$601K 0.01%
10,058
– –
AMGN icon
338
Amgen
AMGN
$204B
$572K 0.01%
3,758
– –
KDP icon
339
Keurig Dr Pepper
KDP
$42.6B
$524K 0.01%
5,420
-3,937
-42% -$361K
ADAP
340
DELISTED
Adaptimmune Therapeutics
ADAP
$513K 0.01%
62,980
– –
HON icon
341
Honeywell
HON
$63.7B
$504K 0.01%
+4,820
New +$495K
NBIX icon
342
Neurocrine Biosciences
NBIX
$15.5B
$504K 0.01%
11,090
– –
BNS icon
343
Scotiabank
BNS
$113B
$486K 0.01%
7,679
+743
+11% +$36.5K
MCD icon
344
McDonald's
MCD
$182B
$484K 0.01%
4,024
-3,832
-49% -$480K
LLY icon
345
Eli Lilly
LLY
$1.02T
$479K ﹤0.01%
6,084
– –
MA icon
346
Mastercard
MA
$500B
$400K ﹤0.01%
4,540
+1,309
+41% +$125K
ROST icon
347
Ross Stores
ROST
$72.2B
$391K ﹤0.01%
6,893
+724
+12% +$40.2K
CNQ icon
348
Canadian Natural Resources
CNQ
$105B
$389K ﹤0.01%
20,234
+461
+2% +$6.52K
KWR icon
349
Quaker Houghton
KWR
$2.61B
$351K ﹤0.01%
3,938
-738
-16% -$64.3K
MGEE icon
350
MGE Energy Inc
MGEE
$2.86B
$350K ﹤0.01%
+6,195
New +$321K
12 13
14
15 16

Similar funds

SG
Societe Generale $14.1B AUM
KGI
KBI Global Investors Ifsc, Dublin, Ireland $3.74B AUM
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

RS Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, RS Investment Management held 438 positions worth $9.73B, down 3.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RS Investment Management withdrew a net $739M in Q2 2016, closing 56 positions and reducing 162 holdings. Its most notable exit was Myriad Genetics, an estimated $81.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, RS Investment Management opened a new position in Kirby Corp worth $52.4M.

  • RS Investment Management's largest Q2 2016 buy was Kirby Corp: 839,753 shares worth $52.4M.
  • RS Investment Management added most to Allergan plc in Q2 2016, an estimated $36.7M increase.
  • RS Investment Management's biggest Q2 2016 reduction was Steris, cutting an estimated $57.7M.
  • RS Investment Management fully exited Myriad Genetics in Q2 2016, selling an estimated $81.5M.
  • RS Investment Management's ten largest holdings make up 15% of its $9.73B portfolio in Q2 2016.
  • RS Investment Management opened 62 new positions and closed 56 in Q2 2016.
  • RS Investment Management's portfolio value fell 3.8% quarter-over-quarter to $9.73B.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.